Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Griffonia simplicifolia extract is a botanical extract derived from the seeds of the *Griffonia simplicifolia* plant, a woody climbing shrub native to West and Central Africa. The extract is highly valued for its high concentration of 5-hydroxytryptophan (5-HTP), a naturally occurring amino acid that serves as the immediate chemical precursor in the biosynthesis of the neurotransmitter serotonin. By facilitating increased serotonin production in the brain, the extract is widely used as a dietary supplement to address conditions associated with low serotonin levels, such as depression, anxiety, insomnia, and migraine. Additionally, it has been studied for its role in appetite suppression and weight management, as well as potential antimicrobial and antiproliferative activities in preclinical models.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on griffonia simplicifolia extract.